Geneferm Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020
November 05, 2020 at 06:19 pm
Share
GeneFerm Biotechnology Co., Ltd. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 92.889 million compared to TWD 80.843 million a year ago. Operating income was TWD 8.516 million compared to operating loss of TWD 352,000 a year ago. Net income was TWD 4.137 million compared to net loss of TWD 2.362 million a year ago. Basic earnings per share was TWD 0.14 compared to basic loss per share of TWD 0.08 a year ago. For the nine months, sales was TWD 264.564 million compared to TWD 232.985 million a year ago. Operating income was TWD 6.869 million compared to operating loss of TWD 13.636 million a year ago. Net loss was TWD 1.556 million compared to TWD 15.901 million a year ago. Basic loss per share was TWD 0.06 compared to TWD 0.57 a year ago.
GeneFerm Biotechnology Co., Ltd. is a Taiwan-based company mainly engaged in the manufacture and sales of health food. Its health food products include fermented products, medicinal mushrooms, lactic acid bacteria products, fruit and vegetable fermented concentrate products, among others. The Company also provides related manufacturing services, as well as health food design, research and development services.